Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia

Journal of Urban Health

Volumn 84, Issue 2, 2007, Pages 255-266

  Kimber, Jo ^a,b   Dolan, Kate ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Blood borne virus risk behavior; Injecting drug use; Shooting galleries; Supervised injecting facilities

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; DRUG MARKETING; DRUG OVERDOSE; FEMALE; HEALTH CARE FACILITY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MALE; POLICE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; BLOOD-BORNE PATHOGENS; CROSS-SECTIONAL STUDIES; DRUG AND NARCOTIC CONTROL; FEMALE; HARM REDUCTION; HOMELESS PERSONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MOTIVATION; NEEDLE-EXCHANGE PROGRAMS; NEW SOUTH WALES; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; PROSTITUTION; QUESTIONNAIRES; RISK-TAKING; STREET DRUGS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH SERVICES;

EID: 33947288436     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9145-3     Document Type: Article

References (47)

1. Kerr T, Small W, Wood E. The public health and social impacts of drug market enforcement: a review of the evidence. Int J Drug Policy. 2005;16(4):210-220.
2. Rhodes T. The "risk environment": a framework for understanding and reducing drugrelated harm. Int J Drug Policy. 2002;13:85-94.
3. Maher L, Dixon D. Policing and public health: law enforcement and harm minimisation in a street-level drug market. Br J Criminol. 1999;39:488-512.
4. Rhodes T, Singer M, Bourgois P, Friedman S, Strathdee S. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026-1044.
5. Des Jarlais DC, Friedman SR. Shooting galleries and AIDS: infection probabilities and "tough" policies. Am J Public Health. 1990;80(2):142-144.
6. Latkin CA, Mandell W, Vlahov D, et al. My place, your place, and no place: behavioural settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994;22(3):415-430.
7. Shapshak P, Fujimura RK, Page JB, et al. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Drug Alcohol Depend. 2000;58:153-157.
8. Battjes RJ, Pickens RW, Haverkos HW, et al. HIV risk factors among injecting drug users in 5 U.S. cities. AIDS. 1994;8(5):681-687.
9. Friedman S, Jose B, Deren S, et al. Risk factors for human immunodeficiency virus seroconversion among out of treatment drug injectors in high prevalence and low prevalence cities. Am J Epidemiol. 1995;142:864-874.
10. Chitwood D, McCoy C, Incardi J, et al. HIV Seropositivity of needles for shooting galleries in South Florida. Am J Public Health. 1990;80:150-152.
11. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1(1):39-44.
12. Nemoto T. Behavioural characteristics of seroconverted intravenous drug users. Int J Addict. 1992;27(12):1413-1421.
13. Carlson R. Shooting galleries, dope houses, and injection doctors: examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Human Organ. 2000;59:325-333.
14. Ouellet LJ, Jimenez A, Johnson W, et al. Shooting galleries and HIV disease: variations in places for injecting illicit drugs. Crime Delinq. 1991;37(1):64-85.
15. Murphy S, Waldorf D. Kickin' down to the street doc: shooting galleries in the San Francisco Bay area. Contemp Drug Probl. 9-29 1991;1991(18):1.
16. Longshore D. Prevalence and circumstances of drug injection at Los Angeles shooting galleries. Crime Delinq. 1996;42(1):21-35.
17. Rutter S, Dolan K, Wodak A. Rooms for rent: injecting and harm reduction in Sydney. Aust N Z J Public Health. 1997;21:105.
18. Wood JRT. Royal Commission Into the New South Wales Police Service. Sydney: Government of New South Wales; 1997.
19. Parliament of New South Wales. Report on the establishment or trial of safe injecting rooms. Joint Select Committee into Safe Injecting Rooms. Sydney: Parliament of New South Wales; 1998.
20. Collins L, van Beek I. Caught in the Crossfire. Paper presented at: 28th Australian Public Health Association Conference, 1996; Perth, Australia.
21. Parliament of New South Wales. Drug Summit Legislative Response Act. 67; 1999.
22. Dolan K, Kimber J, Fry C, et al. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;19:337-346.
23. MSIC Evaluation. Evaluation Protocol for the trial a Medically Supervised Injecting Centre in Kings Cross. Sydney: University of New South Wales; 2001.
24. Day C, Ross J, White B, et al. Australian prevalence and estimation of treatment study: New South Wales Report. Sydney: University of New South Wales; 2002. NDARC Technical Report No. 127.
25. Marshall MN. The key informant technique. Fam Pract. 1996;13(1):92-97.
26. Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict. 1988;83:649-654.
27. Joffe H, Yardley L. Content and Thematic Analysis. In: Marks D, Yardley L, eds. Research Methods for Clinical and Health Psychology. London: Sage Publications; 2004.
28. Wodak A, Symonds A, Richmond R. The role of civil disobedience in drug policy reform: how an illegal "safer injection room" led to a sanctioned "medically supervised injecting centre". J Drug Issues. 2003;33(3):609-624.
29. Latkin CA, Mandell W, Vlahov D, et al. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Soc Netw. 1995;17:219-228.
30. Page JB, Smith PC, Kane N. Shooting galleries, their proprietors, and implications for prevention of AIDS. Drugs Soc. 1990;5:69-85.
31. Celentano DD, Vlahov D, Cohn S, et al. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81(10):1291-1295.
32. Robles R, Marrero CA, Reyes JC, et al. Risk behaviours, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. J Acquir Immune Defic Syndr Human Retrovirol. 1998;17(5):477-483.
33. Colon HM, Robles R, Sahai H, et al. Changes in HIV risk behaviors among intravenous drug users in San Juan, Puerto Rico. Br J Addict. 1992;87(4):585-590.
34. Friedman SR, Des Jarlais DC. HIV among drug injectors: the epidemic and the response. AIDS Care. 1991;3(3):239-250.
35. Nemoto T, Foster K, Brown L. Effect of psychological factors on risk behavior of human inmmunodeficiency virus (HIV) infection among intravenous drug users (IVDUs). Int J Addict. 1991;26(4):441-456.
36. Kaplan EH. Needles that kill: modelling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis. 1989;11(2):289-298.
37. Strathdee S, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
38. Kerr T, Wood E, Small D, et al. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ, Can Med Assoc J. 2003; 169(8):759-763.
39. Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Aust N Z J Public Health. 1999;23:501-504.
40. Kaye S, Darke S, McKetin R. The Prevalence, Patterns and Harms of Cocaine Use Among Injecting and Non-Injecting Drug Users in Sydney. Sydney: University of New South Wales; 2000. NDARC Technical Report No. 99.
41. Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend. 2003;70:275-286.
42. Day C, Degenhardt L, Gilmour S, et al. Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. Br Med J. 2004;329:428-429.
43. Day C, Topp L, Rouen D, et al. Decreased heroin availability in Sydney Australia in early 2001. Addiction. 2003;98:93-95.
44. van Beek I. Approaches to injecting drug use in Kings Cross: a review of the last 10 years. NSW Public Health Bull. 2000;11(4):54-55.
45. Kimber J, Hickman M, Degenhardt L, et al. Estimating the size of the local IDU population using client visits to the Sydney medically supervised injecting centre. Paper presented at: 16th International Conference on the reduction of drug related harm; 20-24 March, 2005; Belfast, Northern Ireland.
46. Kimber J, Dolan K, van Beek I, et al. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22:227-233.
47. Stimson GV, Hickman M, Rhodes T, et al. Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions. Int J Drug Policy. 2005;16(Suppl 1):7-20.